share_log

丽珠集团:2024年净利润20.61亿元 同比增长5.50%

Livzon Pharmaceutical Group Inc.: In 2024, the Net income is 2.061 billion yuan, a year-on-year increase of 5.50%.

Breakings ·  Mar 26 09:58

Livzon Pharmaceutical Group Inc. announced that in 2024, the revenue is 11.812 billion yuan, a year-on-year decrease of 4.97%. The Net income attributable to shareholders of the listed company is 2.061 billion yuan, an increase of 5.50% year-on-year. The company intends to distribute a cash dividend of 11 yuan (including tax) for every 10 shares to all shareholders.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 281

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.